Tag archive for ‘departure of TEVA CEO Jeremy Levin’
Shiri Habib-Valdhorn On Monday, November 4th, 2013

JPMorgan Downgrades Teva Again

– JPMorgan has downgraded Teva to “Underweight”, just two months after downgrading it to “Neutral.” – JPMorgan has downgraded Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; More...

Wordpress site Developed by Fixing WordPress Problems